4,6-dimethoxy-2-(phenylethynyl)pyrimidine | 329206-02-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4,6-dimethoxy-2-(phenylethynyl)pyrimidine
• 英文别名: 4,6-dimethoxy-2-(2-phenylethynyl)pyrimidine
• CAS: 329206-02-2
• 化学式: C₁₄H₁₂N₂O₂
• 分子量: 240.261
• InChiKey: KPLIZRBOUQGAKU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  44.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4,6-dimethoxy-2-(phenylethynyl)pyrimidine 、 、 二氯甲烷 在 乙酸乙酯 作用下， 以 乙醚 为溶剂， 反应 16.0h， 以to afford 4,6-dimethoxy-2-(phenylethynyl)pyrimdine hydrochloride (174 mg, 47% yield) as a yellow solid的产率得到4,6-dimethoxy-2-(phenylethynyl)pyrimdine hydrochloride
  参考文献：
  名称：

  Pyridazine, pyrimidine and pyrazine ethyne compounds

  摘要：

  根据本发明，提供了一种新的杂环化合物类。该发明的化合物包含一个取代或未取代的六元杂环环，其中包括至少两个氮原子。该环还包括四个碳原子。杂环环在靠近环氮原子的环位置上至少有一个取代基。该环的强制性取代基包括一个通过碳-碳三键与杂环环相连的基团(B)。强制性取代基位于环氮原子的旁边。该发明的化合物能够具有广泛的用途。例如，杂环化合物可以通过作为神经系统受体的激动剂和拮抗剂来调节生理过程。该发明的化合物还可以作为杀虫剂和杀菌剂。含有该发明化合物的药物组合物也具有广泛的实用性。

  公开号：

  US20050245542A1
• 作为产物：
  描述：

  2,2-dibromostyrene 在 正丁基锂 、 1-乙酸基-1,2-苯碘酰-3-(1H)-酮 、 Eosin Y 作用下， 以 四氢呋喃 、 正己烷 、 1,2-二氯乙烷 为溶剂， 反应 14.0h， 生成 4,6-dimethoxy-2-(phenylethynyl)pyrimidine
  参考文献：
  名称：

  可见光催化亚烷基二铵盐与炔基羧酸的脱羧烷基化反应：通过有机光氧化还原催化直接进入芳基炔烃

  摘要：

  开发了一种由光氧化还原催化介导的简便方法，用于直接构建芳基炔烃。现成的芳族重氮盐已被用作芳基自由基源，以偶联炔基羧酸以形成脱羧芳基化。各种各样的底物都适合该方案，具有宽泛的官能团耐受性，并且可以使用可见光在温和，中性和无过渡金属的反应条件下合成功能多样的芳基炔烃。除了与光催化和无过渡金属操作相关的合成可持续性外，该方法的另一个关键点是有机染料催化剂可作为激发态还原剂，从而建立了自由基加成和脱羧消除的淬灭循环。

  DOI：

  10.1002/adsc.201900603

文献信息

• Imidazolyl and pyrazolyl ethyne compounds
  申请人：Cosford D. Nicholas

  公开号：US20050085523A1

  公开（公告）日：2005-04-21

  In accordance with the present invention, there is provided a novel class of heterocyclic compounds. Compounds of the invention contain a substituted, unsaturated five, six or seven membered heterocyclic ring that includes at least one nitrogen atom and at least one carbon atom. The ring additionally includes three, four or five atoms independently selected from carbon, nitrogen, sulfur and oxygen atoms. The heterocyclic ring has at least one substituent located at a ring position adjacent to a ring nitrogen atom. This mandatory substituent of the ring includes a moiety (B), linked to the heterocyclic ring via a carbon-carbon double bond, a carbon-carbon triple bond or an azo group. The mandatory substituent is positioned adjacent to the ring nitrogen atom. Invention compounds are capable of a wide variety of uses. For example heterocyclic compounds can act to modulate physiological processes by functioning as agonists and antagonists of receptors in the nervous system. Invention compounds may also act as insecticides, and as fungicides. Pharmaceutical compositions containing invention compounds also have wide utility.

  根据本发明，提供了一类新型的杂环化合物。该发明的化合物包含一个取代的、不饱和的五、六或七元杂环环，其中至少包含一个氮原子和至少一个碳原子。该环另外包括三、四或五个独立选择的碳、氮、硫和氧原子。杂环环在至少一个邻近环氮原子的环位置上具有至少一个取代基。该环的强制性取代基包括一个通过碳-碳双键、碳-碳三键或偶氮基与杂环环相连的基团（B）。强制性取代基位于环氮原子的邻近位置。本发明的化合物能够具有各种用途。例如，杂环化合物可以通过作为神经系统受体的激动剂和拮抗剂来调节生理过程。本发明的化合物也可以作为杀虫剂和杀菌剂。含有本发明化合物的药物组合物也具有广泛的用途。
• Thiazolyl(pyridyl)ethyne compounds
  申请人：——

  公开号：US20030055247A1

  公开（公告）日：2003-03-20

  In accordance with the present invention, there is provided a novel class of heterocyclic compounds. Compounds of the invention contain a substituted, unsaturated five, six or seven membered heterocyclic ring that includes at least one nitrogen atom and at least one carbon atom. The ring additionally includes three, four or five atoms independently selected from carbon, nitrogen, sulfur and oxygen atoms. The heterocyclic ring has at least one substituent located at a ring position adjacent to a ring nitrogen atom. This mandatory substituent of the ring includes a moiety (B), linked to the heterocyclic ring via a carbon-carbon double bond, a carbon-carbon triple bond or an azo group. The mandatory substituent is positioned adjacent to the ring nitrogen atom. Invention compounds are capable of a wide variety of uses. For example heterocyclic compounds can act to modulate physiological processes by functioning as agonists and antagonists of receptors in the nervous system. Invention compounds may also act as insecticides, and as fungicides. Pharmaceutical compositions containing invention compounds also have wide utility.

  根据本发明，提供了一类新型的杂环化合物。该发明的化合物包含一个取代的、不饱和的五、六或七元杂环环，其中至少包含一个氮原子和至少一个碳原子。该环另外包括三、四或五个独立选择的碳、氮、硫和氧原子。杂环环在靠近环氮原子的环位置上至少有一个取代基。该环的强制性取代基包括一个通过碳-碳双键、碳-碳三键或偶氮基与杂环环相连的基团（B）。强制性取代基位于环氮原子的相邻位置。本发明的化合物具有各种用途。例如，杂环化合物可以通过作为神经系统受体的激动剂和拮抗剂来调节生理过程。本发明的化合物也可以作为杀虫剂和杀菌剂。含有本发明化合物的药物组合物也具有广泛的用途。
• Decarboxylative/Sonogashira-type cross-coupling using PdCl₂(Cy*Phine)₂
  作者：Yong Yang、Yee Hwee Lim、Edward G. Robins、Charles W. Johannes

  DOI：10.1039/c6ra12916a

  日期：——

  Expedient protocol to access a wide range of internal alkynes and symmetrical di(heteroaryl)alkynesviatandem decarboxylative–Sonogashira cross-coupling.

  通过串联脱羧化-Sonogashira交叉偶联方法访问广泛的内部炔烃和对称的双(杂环烷基)炔烃。
• [EN] HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSES HETEROCYCLIQUES ET PROCEDES D'UTILISATION DE CEUX-CI
  申请人：MERCK & CO INC

  公开号：WO2001016121A1

  公开（公告）日：2001-03-08

  In accordance with the present invention, there are provided novel class of heterocyclic compounds and methods of use thereof. Compounds of the invention contain a substituted, unsaturated five, six or seven membered heterocyclic ring that includes at least one nitrogen atom and at least one carbon atom. At a ring position adjacent to a ring nitrogen atom, the heterocyclic ring has at least one substituent which includes a moiety, linked to the heterocyclic ring via an alkylene moiety, an alkynylene moiety or an azo group. Invention compounds are capable of a wide variety of uses including modulating physiological processes by functioning as agonists and antagonists of receptors in the nervous system, as insecticides, and as fungicides. The invention further provides methods of modulating the activity of excitatory amino acid receptors using a specifically defined class of heterocyclic compounds including the novel compounds referred to above. In one embodiment, there are provided methods of modulating metabotropic glutamate receptors. The present invention also discloses methods of treating disease using heterocyclic compounds. The invention further discloses methods of preventing disease conditions related to diseases of the pulmonary system, diseases of the nervous system, diseases of the cardiovascular system, diseases of the gastrointestinal system, diseases of the endocrine system, diseases of the exocrine system, diseases of the skin, cancer and diseases of the ophthalmic system. The invention also discloses pharmaceutically acceptable salt forms of the above-described heterocyclic compounds.

  根据本发明，提供了一类新型的杂环化合物及其使用方法。该发明的化合物包含一个取代的、不饱和的五、六或七元杂环环，其中至少包含一个氮原子和至少一个碳原子。在靠近环氮原子的环位置上，杂环环有至少一个取代基，包括一个官能团，通过烷基官能团、炔基官能团或偶氮基团连接到杂环环上。发明的化合物能够广泛应用，包括通过作为神经系统受体的激动剂和拮抗剂来调节生理过程，作为杀虫剂和杀菌剂。本发明还提供了使用特定定义的杂环化合物类来调节兴奋性氨基酸受体活性的方法，包括上述新型化合物。在一种实施例中，提供了调节代谢性谷氨酸受体的方法。本发明还揭示了使用杂环化合物治疗疾病的方法。本发明还揭示了预防与肺系统疾病、神经系统疾病、心血管系统疾病、胃肠系统疾病、内分泌系统疾病、外分泌系统疾病、皮肤疾病、癌症和眼科系统疾病相关的疾病状态的方法。本发明还揭示了上述杂环化合物的药物可接受的盐形式。
• HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
  申请人：Merck & Co., Inc.

  公开号：EP1214303A1

  公开（公告）日：2002-06-19